© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
DaVita Inc. (DVA) stock declined over -2.27%, trading at $137.64 on NYSE, down from the previous close of $140.83. The stock opened at $140.00, fluctuating between $136.22 and $140.97 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 09, 2026 | 140.00 | 141.50 | 136.19 | 137.64 | 1.49M |
| Feb 06, 2026 | 149.00 | 151.42 | 139.54 | 140.83 | 2.25M |
| Feb 05, 2026 | 143.68 | 150.45 | 142.51 | 149.22 | 2.22M |
| Feb 04, 2026 | 136.06 | 147.60 | 135.90 | 142.06 | 3.04M |
| Feb 03, 2026 | 128.00 | 139.86 | 125.00 | 134.73 | 4.81M |
| Feb 02, 2026 | 109.06 | 111.33 | 108.88 | 111.19 | 2.36M |
| Jan 30, 2026 | 107.12 | 109.50 | 105.41 | 109.34 | 1.08M |
| Jan 29, 2026 | 106.00 | 107.76 | 105.51 | 107.24 | 1.15M |
| Jan 28, 2026 | 104.75 | 106.85 | 104.06 | 105.88 | 709.47K |
| Jan 27, 2026 | 106.79 | 106.96 | 105.03 | 105.61 | 750.09K |
| Jan 26, 2026 | 108.40 | 108.61 | 106.70 | 107.51 | 583.31K |
| Jan 23, 2026 | 108.64 | 109.16 | 107.40 | 108.12 | 1.03M |
| Jan 22, 2026 | 107.33 | 110.43 | 107.20 | 109.17 | 903.28K |
| Jan 21, 2026 | 103.90 | 106.69 | 103.90 | 106.30 | 970.25K |
| Jan 20, 2026 | 103.91 | 105.12 | 103.48 | 103.93 | 921.9K |
| Jan 16, 2026 | 104.94 | 106.32 | 104.20 | 104.74 | 649.78K |
| Jan 15, 2026 | 103.25 | 106.38 | 102.26 | 105.84 | 948.63K |
| Jan 14, 2026 | 104.00 | 104.86 | 101.00 | 103.87 | 2.11M |
| Jan 13, 2026 | 110.00 | 110.10 | 104.24 | 104.47 | 1.08M |
| Jan 12, 2026 | 111.49 | 111.72 | 109.59 | 110.10 | 565.92K |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
| Employees | 76000 |
| Beta | 1.01 |
| Sales or Revenue | $12.14B |
| 5Y Sales Change% | 1.002% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |